Sign In
Buy ILMN
$170.93
+8.38 (+5.16%)
At Close: Jun 03, 2026
Calvin Klein Parent PVH, Illumina Put on China's 'Unreliable Entity' List
11:36am, Tuesday, 04'th Feb 2025
Shares of Calvin Klein parent PVH (PVH) and biotech firm Illumina (ILMN) fell when China announced that the companies were being added to its "unreliable entity" list.
China retaliates against US with tariffs, antitrust probes
11:26am, Tuesday, 04'th Feb 2025
China retaliated against US tariffs on Tuesday by imposing additional duties on American goods like coal, crude oil (BZ=F, CL=F), and farm equipment. Initially, President Donald Trump announced a 10%
China puts PVH Corp, Illumina on its unreliable entity list
12:57am, Tuesday, 04'th Feb 2025
China's Commerce Ministry said on Tuesday that it had put PVH Corp and Illumina on its unreliable entity list after the two companies took what it called "discriminatory measures against Chinese enter
Curious about Illumina (ILMN) Q4 Performance? Explore Wall Street Estimates for Key Metrics
10:21am, Monday, 03'rd Feb 2025
Besides Wall Street's top -and-bottom-line estimates for Illumina (ILMN), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the q
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:51am, Monday, 03'rd Feb 2025
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
ANGLE CEO on Illumina collaboration - ICYMI
10:09am, Friday, 31'st Jan 2025
ANGLE PLC (AIM:AGL, OTCQX:ANPCY) Chief Executive Andrew Newland talked with Proactive about the company's recent breakthrough in dual ctDNA and CTC DNA analysis on the Illumina platform. The six-month
Illumina (ILMN) Earnings Expected to Grow: Should You Buy?
11:07am, Thursday, 30'th Jan 2025
Illumina (ILMN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Dividends And Dynamite: 10 High-Yield Blue-Chip Bargains You Don't Want To Miss
07:00am, Thursday, 30'th Jan 2025
A “Dividend and Dynamite” approach that pairs ultra‐yielding blue chips with top‐tier growth stocks, delivering not only robust current income but also strong long‐term appreciation and 3X m
Here's Why Illumina (ILMN) is a Strong Momentum Stock
10:51am, Thursday, 23'rd Jan 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:56am, Tuesday, 21'st Jan 2025
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Why Illumina (ILMN) is Poised to Beat Earnings Estimates Again
01:15pm, Thursday, 16'th Jan 2025
Illumina (ILMN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:55am, Thursday, 16'th Jan 2025
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Illumina Partners NVIDIA for Genomic Advancements, ILMN Stock Climbs
08:25am, Thursday, 16'th Jan 2025
ILMN teams up with NVIDIA to advance technology platforms for the analysis and interpretation of multiomic data.
Illumina, Inc. (ILMN) 43rd Annual JPMorgan Healthcare Conference - (Transcript)
02:21pm, Tuesday, 14'th Jan 2025
Illumina, Inc. (NASDAQ:ILMN ) 43rd Annual JPMorgan Healthcare Conference Call January 14, 2025 12:00 PM ET Company Participants Jacob Thaysen - Chief Executive Officer Ankur Dhingra - Chief Financial
SAN DIEGO , Jan. 14, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) ("Illumina" or the "company") today announced unaudited preliminary financial results for the fourth quarter and fiscal year 202
